Nuzenio

Cancer Clinical Trials

Cancer Clinical Trials news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 14 publisher sources 100/100 entity strength

Latest news

First patient dosed with AK146D1 in Akeso’s Phase II study - Clinical Trials ArenaClinical Trials Arena · Mon, 10 Aug 2026 10:27:11 GMTClinical Trials Round-Up: May and June 2026 - pharmaphorumpharmaphorum · Mon, 10 Aug 2026 08:57:56 GMTThe promise of radiopharmaceuticals smacks into safety concerns - STATSTAT · Mon, 10 Aug 2026 08:33:33 GMTChanging the rules of brain cancer research. - Minderoo FoundationMinderoo Foundation · Mon, 10 Aug 2026 06:10:29 GMTAkeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 04:31:46 GMTNew drug delivers promising survival gains in pancreatic cancer - news-medical.netnews-medical.net · Mon, 10 Aug 2026 03:11:00 GMTStudy identifies barriers to equitable pediatric cancer trial participation - news-medical.netnews-medical.net · Mon, 10 Aug 2026 03:02:00 GMTOncoPRO Helps Practices Navigate ePRO Adoption - Targeted OncologyTargeted Oncology · Mon, 10 Aug 2026 00:00:00 GMT

Timeline

Mon, 10 Aug 2026 10:27:11 GMTFirst patient dosed with AK146D1 in Akeso’s Phase II study - Clinical Trials Arena
Mon, 10 Aug 2026 08:57:56 GMTClinical Trials Round-Up: May and June 2026 - pharmaphorum
Mon, 10 Aug 2026 08:33:33 GMTThe promise of radiopharmaceuticals smacks into safety concerns - STAT
Mon, 10 Aug 2026 06:10:29 GMTChanging the rules of brain cancer research. - Minderoo Foundation
Mon, 10 Aug 2026 04:31:46 GMTAkeso Advances IO2.0 + ADC2.0 Strategy: First Patient Dosed in Phase II Study of TROP2/Nectin-4 Bispecific ADC (AK146D1) Combined with Ivonescimab in Breast Cancer - The Manila Times
Mon, 10 Aug 2026 03:11:00 GMTNew drug delivers promising survival gains in pancreatic cancer - news-medical.net

Related explainers

HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.PoliticsPolitics stories explain decisions, institutions, parties, leaders, laws, budgets, elections, courts, and public accountability.

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Cancer Clinical Trials.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.